Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Investor Update - May

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Jun 02, 2022 11:02am

123 Views

Post# 34726514

RE:Investor Update - May

Per slide 10

"Worst case" Interim enrollment achieved Oct 31, 2022

(this assumes 0.5 enrollees per site, per month)

*Assumes ICU impact of COVID Omicron variant subsides in March 2022

https://ourworldindata.org/grapher/current-covid-patients-icu

MM

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project